Aliceblue ANT
Aliceblue ANTInstall and trade smarter everywhere
C

Citichem India Ltd

Complete IPO details, including price band, financials, subscription status, and key insights.

Participate in the Citichem India Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.

IPO Snapshot

Key metrics and details at a glance.

Price Band

₹70

Per Share

Lot Size

2000 Shares

Minimum Investment

₹1,40,000

Issue Size

₹12.6 Cr

Face Value

₹10

Per Share

IPO Type

Fixed Price - SME

Retail Quota

50%

QIB Quota

0%

NII Quota

50%

IPO Timeline

Important dates for your applying strategy.

IPO Opens27 Dec
IPO Closes31 Dec
Basis of Allotment1 Jan
Refund Initiation2 Jan
Shares Credited2 Jan
Listing Date3 Jan
IPO Process Completed

Subscription Status

Live demand across investor categories.

Track real-time subscription levels:

*Real-time data subject to exchange updates

Qualified Institutional Buyers (QIB)0.00x
Non-Institutional Investors (NII)0.00x
Retail Individual Investors (RII)0.00x
Overall Subscription0.00x

Citichem India Ltd

Business model, operations, and market positioning.

Promoter Holding (Pre-Issue)

83.25%

Promoter Holding (Post-Issue)

61.21%

Issue Type

Fixed Price - SME

ISIN

INE0A8401016

About the Company

Citichem India Limited is mainly engaged in the buying, procuring, and supplying, of organic and inorganic chemicals, bulk drugs, and, food chemicals to pharmaceutical industry. The traded speciality chemicals and intermediates have a wide application in aluminium, steel, textiles, paper, dairy, paints, dyes & intermediates, soap making, pharma, food and adhesive Industry. The Company also supplies food preventives and chemicals under its own brand name which is thereafter converted into sales in its own books by the distribution team who ensures safe delivery of bulk supply. The said works are primarily sourced through its leased Registered Office located at 7, Floor 1, Plot No 96, Dhram Jyoti, Kazi Sayed Street, Khand Bazar, Masjid Station, Mandvi, Mumbai - 400003, Maharashtra, India.

Industry Overview

Covering more than 80,000 commercial products, India's chemical industry is extremely diversified and can be broadly classified into bulk chemicals, specialty chemicals, agrochemicals, petrochemicals, polymers and fertilisers. Globally, India is the fourth-largest producer of agrochemicals after the United States, Japan and China. India accounts for ~16% of the world production of dyestuffs and dye intermediates. Indian colorants industry has emerged as a key player with a global market share of ~15%. The country's chemicals industry is de-licensed, except for few hazardous chemicals. India holds a strong position in exports and imports of chemicals at a global level and ranks 9th in exports and 6th in imports at global level (excluding pharmaceuticals).

Company History

Citichem India Limited was incorporated as `Citichem Alkalies (Bombay) Private Limited' pursuant to a Certificate of Incorporation dated March 18, 1992, issued by the Registrar of Companies, Maharashtra, as a private company under the provisions of the Companies Act, 1956. Further, the Company was converted into public limited company and consequently name of the Company was changed from `Citichem Alkalies (Bombay) Private Limited' to `Citichem Alkalies (Bombay) Limited' vide special resolution passed by the shareholders of the Company at an extra-ordinary general meeting held on March 01, 1999, and a fresh certificate of incorporation dated March 12, 1999 was issued by Registrar of Companies, Maharashtra. Thereafter, pursuant to fresh certificate of incorporation dated April 17, 1999, the name of the company has been changed from `Citichem Alkalies (Bombay) Limited' to `Citichem India Ltd'. The Corporate Identification Number of the Company is U24100MH1992PLC065975.

Products & Services

  • Citichem India Limited is mainly engaged in the buying, procuring, and supplying, of organic and inorganic chemicals, bulk drugs, and, food chemicals to pharmaceutical industry.

Growth Strategy

  • Increase Market Presence.
  • Focus on increasing its domestic sales.
  • Increasing Operational efficiency.
  • Increase by targeting unexplored markets.
  • Expand its scope by adding more products.
  • Continue to strive for cost efficiency.
  • Scale up branding, promotional, and digital activities.
  • Improving operational efficiencies.
  • Asset-light model.

Customer Base

Wholesaler and Retailer

Financial Performance

Revenue, profit after tax and total assets across the last 3 reported financial years.

Standalone figures
Financial Performance Categories

Revenue

+160%vs FY23

Amount in ₹ crore

20.9
19.6
54.4
FY23FY24FY25

Profit After Tax (PAT)

+242%vs FY23

Amount in ₹ crore

0.36
1.39
1.23
FY23FY24FY25

Total Assets

−12.3%vs FY23

Amount in ₹ crore

79.7
69.3
69.9
FY23FY24FY25

Figures in ₹ crore, on a standalone basis, as reported for FY23 to FY25.

Objects of the Issue

How the company plans to utilize IPO proceeds.

Use of Proceeds

The funds raised through this IPO will be used for:

Initial public issue of upto 18,00,000 equity shares of face value of Rs. 10 each of Citichem India Limited (the "Company" or the "Issuer") for cash at a price of Rs. 70/- per equity share including a share premium of Rs. 60/- per equity share (the "Issue Price") aggregating to Rs. 12.60 crores ("The Issue"), of which up to 92,000 equity shares for cash at a price of Rs. 70/- per equity share including a share premium of Rs. 60/- per equity share aggregating to Rs. 0.64 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e., net issue of 17,08,000 equity shares at a price of Rs. 70/- per equity share aggregating to Rs. 11.96 crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 26.47% and 25.12% respectively of the post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10/- each and the issue price is 7 times of the face value.

*Subject to approvals and market conditions.

Strengths & Risks

Key competitive advantages and factors to consider before investing.

Strengths and Risk Factors
  • Quality and focus on customer satisfaction.
  • Expertise.
  • Satisfactory track record.
  • There are outstanding actions and litigation proceedings against the Company, Promoter and Directors. Any adverse outcome in such proceedings may have an adverse impact on its reputation, business, financial condition, results of operations and cash flows.
  • There have been instances of delays of certain forms which were required to be filed as per the reporting requirements under the Companies Act, 2013 to RoC.
  • Majority of its revenues are dependent on few customers and the loss of, or a significant reduction in purchases by such customers could adversely affect its financial performance.
  • The company business involves trading of the hazardous, corrosive and flammable industrial chemicals, which require expert handling and storage, as applicable and which entails significant risks and could also result in enhanced obligations. Any accidents may result in loss of life or property and disrupt its operations which may have an adverse effect on the company results of operation, cash flows and financial condition.
  • The Company does not have any registered Trademarks.

Frequently Asked Questions

01

What is the minimum investment required to apply for this IPO?

The minimum investment depends on the lot size and the upper price band of the issue. Investors must apply for at least one lot, and the total investment amount is calculated by multiplying the lot size by the upper price band.
02

How is IPO allotment decided?

IPO allotment is determined based on demand and SEBI guidelines. If the IPO is oversubscribed in the retail category, allotment is typically done through a computerized lottery system to ensure fair distribution among eligible applicants.
03

When will I know if shares are allotted to me?

Allotment status is usually finalized a few days after the IPO closes. Once finalized, shares are either credited to your Demat account (if allotted) or the blocked funds are released back to your bank account.
04

Can I modify or cancel my IPO application?

Yes, you can modify or cancel your IPO application anytime before the IPO closing date. Changes can be made through your Alice Blue account, subject to exchange cut-off timings.
05

What happens if the IPO is oversubscribed?

If the IPO receives more applications than the number of shares available, it is considered oversubscribed. In such cases, allotment in the retail category is done on a proportionate or lottery basis, and not all applicants may receive shares.